Catherine Owen Adams
Tracked across 2 events · 13 articles · First seen Jun 26, 2026 · Last active Aug 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Catherine Owen Adams, CEO of Acadia Pharmaceuticals Inc., expressed satisfaction with the CHMP's positive opinion, highlighting the company's commitment to addressing unmet medical needs.
Jun 26, 2026 · 6 articles
Regulatory
Impact: CEO of Acadia, who commented on the approval, highlighting its significance for the Rett syndrome community.
Aug 24, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Catherine Owen Adams live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard